Objective
To measure the levels of B lymphocyte stimulating factor (BLyS/BAFF)and its receptors in non-Hodgkin's lymphoma (NHL) and to determine the relationship between BAFF and receptors level with NHL.
Methods
Serum levels of BAFF, its receptor and blood mononuclear cell(PBMC) BAFF mRNA levels of 47 NHL patients and 20 controls were determined by ELISA and real-time quantitative PCR. Paired-samples t test was used to compare the differences of serum BAFF, its receptor and BAFF mRNA levels between NHL patients and healthy controls. Meanwhile, the correlations between the expression of BAFF and its receptors and the concentration of lactate dehydrogenase (LDH), β2-microglobulin(β2M) were estimated.
Results
Compared with controls, NHL patients had significantly higher levels of BAFF PBMC mRNA (0.48±0.02 vs. 0.25±0.02, t=17.75, P=0.000). Serum BAFF and its receptors TACI,BCMA, BAFF-R levels in NHL patients [(19.18±1.29) ng/ml, (212.74±7.98) pg/ml, (102.98 ±6.18) pg/ml,(2.95±0.19) ng/ml] were significantly higher than those in healthy controls [(10.94±1.56) ng/ml,(139.00±12.51) pg/ml, (59.66±7.06) pg/ml, (1.34±0.26) ng/ml, t values were 7.05, 8.61, 7.99, 8.66,P<0.01]. Compared with the normal LDH group, the elevated LDH group had significantly higher levels of LDH [(310.96±108.00) U/L vs (142.65±36.00) U/L, t=4.697, P<0.05] , there were also significant differences in BAFF, BCMA and BAFF mRNA expression between the two groups (t values were 21.060, 7.254, 6.658, respectively, P<0.05). However, there was no significant correlation between BAFF mRNA, serum BAFF and its receptors and β2M, LDH (r=0.026, 0.014, 0.127, 0.001, 0.003;0.201, 0.093, 0.015, 0.031, 0.169, respectively, P>0.05).
Conclusion
Serum BAFF, and PMBC BAFF mRNA levels are significantly elevated in NHL patients, suggesting that BAFF and its receptors may be involved in the pathogenesis of NHL and those expression may associate with the activity of NHL.